Imaging techniques for the evaluation of ovarian cancer

被引:57
作者
Fischerova, Daniela [1 ,2 ]
Burgetova, Andrea [2 ,3 ]
机构
[1] Charles Univ Prague, Fac Med 1, Dept Obstet & Gynecol, Gynecol Oncol Ctr, Prague 12000, Czech Republic
[2] Charles Univ Prague, Gen Univ Hosp, Prague 12000, Czech Republic
[3] Charles Univ Prague, Fac Med 1, Dept Radiol, Prague 12000, Czech Republic
关键词
ovarian cancer staging; FIGO staging; follow up; ultrasound; CT; MRI; PET/CT; POSITRON-EMISSION-TOMOGRAPHY; DIFFUSION-WEIGHTED MRI; SUBOPTIMAL PRIMARY CYTOREDUCTION; PET/CONTRAST-ENHANCED CT; TRU-CUT BIOPSY; COMPUTED-TOMOGRAPHY; FDG-PET/CT; FOLLOW-UP; PERITONEAL CARCINOMATOSIS; NEOADJUVANT CHEMOTHERAPY;
D O I
10.1016/j.bpobgyn.2014.04.006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Women with ovarian cancer often present at advanced stage of disease. The outcome depends mainly on the stage of disease at first diagnosis, but also on the quality of treatment. For individualised tumour treatment, detailed assessment of tumour extension using modern imaging is crucial. Ultrasound remains the initial and most important imaging method for ovarian cancer detection. Although increasing evidence shows that ultrasound is an accurate technique to stage and follow up ovarian cancer, it requires an experienced examiner capable of examining both the pelvis and the abdomen. Computed tomography is the most commonly used imaging modality for preoperative staging and follow up. Magnetic resonance imaging remains a second-line imaging method for solving problems, mainly in the pelvis. Positron emission tomography combined with computed tomography is the optimal imaging technique for suspected recurrence, particularly in women with rising CA 125 levels, but negative results of conventional imaging methods. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:697 / 720
页数:24
相关论文
共 113 条
[1]   Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment [J].
Aletti, Giovanni D. ;
Eisenhauer, Eric L. ;
Santillan, Antonio ;
Axtell, Allison ;
Aletti, Giacomo ;
Holschneider, Christine ;
Chi, Dennis S. ;
Bristow, Robert E. ;
Cliby, William A. .
GYNECOLOGIC ONCOLOGY, 2011, 120 (01) :23-28
[2]   Imaging of Female Pelvic Malignancies Regarding MRI, CT, and PET/CT Part 2 [J].
Alt, Celine D. ;
Brocker, Kerstin A. ;
Eichbaum, Michael ;
Sohn, Christof ;
Arnegger, Florian U. ;
Kauczor, Hans-Ulrich ;
Hallscheidt, Peter .
STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (11) :705-714
[3]  
[Anonymous], 2003, PATHOLOGY GENETICS T
[4]  
Avril N, 2004, J NUCL MED, V45, P930
[5]   Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer [J].
Avril, N ;
Sassen, S ;
Schmalfeldt, B ;
Naehrig, J ;
Rutke, S ;
Weber, WA ;
Werner, M ;
Graeff, H ;
Schwaiger, M ;
Kuhn, W .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7445-7453
[6]   Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer [J].
Axtell, Allison E. ;
Lee, Margaret H. ;
Bristow, Robert E. ;
Dowdy, Sean C. ;
Cliby, William A. ;
Raman, Steven ;
Weaver, John P. ;
Gabbay, Mojan ;
Ngo, Michael ;
Lentz, Scott ;
Cass, Ilana ;
Li, Andrew J. ;
Karlan, Beth Y. ;
Holschneider, Christine H. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (04) :384-389
[7]  
Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209
[8]   Ovarian Cancer Management: The role of imaging and diagnostic challenges [J].
Bharwani, Nishat ;
Reznek, Rodney H. ;
Rockall, Andrea G. .
EUROPEAN JOURNAL OF RADIOLOGY, 2011, 78 (01) :41-51
[9]   Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT [J].
Bristow, RE ;
del Carmen, MG ;
Pannu, HK ;
Cohade, C ;
Zahurak, ML ;
Fishman, EK ;
Wahl, RL ;
Montz, FJ .
GYNECOLOGIC ONCOLOGY, 2003, 90 (03) :519-528
[10]   MEDICAL PROGRESS - CANCER OF THE OVARY [J].
CANNISTRA, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (21) :1550-1559